PROGRAM OBJECTIVES
After this Symposium, participants will be able to:
- Recognize the relevance of the tumor microenvironment as it pertains to non-Hodgkin’s lymphoma.
- Discuss the biologic predictors and implications on treatment in follicular lymphoma.
- Discuss the role of stem cell transplantation in follicular lymphoma.
- Review the emerging pathways and associated targeted treatment options for patients with Hodgkin disease.
- Demonstrate knowledge on the treatment strategies available for patients with mantle cell lymphoma.
- Evaluate the available treatment options for patients with newly diagnosed chronic lymphocytic leukemia.
SCIENTIFIC PROGRAM
Friday, April 17, 2009
12:00 - 17:00
Registration Open
Burham Ballroom Foyer
14:30 - 18:00
Exhibition Hall Open
Burnham Ballroom C&D
13:00 - 14:45
SESSION I
Translational/Pathology
Burnham Ballroom A&B
13:00 - 13:15
Welcome and Overview
13:15 - 14:00
Ken Cohen, MD
University of Chicago
NHL microenvironment
14:00 - 14:45
Eric Hsi, MD
Cleveland Clinic
Biologic predictors and implications on treatment in follicular lymphoma
14:45 - 15:05
Break in Exhibit Hall
Burnham Ballroom C&D
15:05 - 17:00
SESSION I CONTINUED
Translational/Pathology
Burnham Ballroom A&B
15:05 - 15:50
Andrew Evens, DO, MS
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Rational Pathways to Target in Hodgkin lymphoma
15:50 - 16:35
Neil Kay, MD
Mayo Clinic
Novel approaches and agents for the treatment of relapsed/refractory CLL
16:35 - 17:00
POSTER DISCUSSION SESSION
Sonali Smith, MD
University of Chicago
17:00 - 18:00
Reception and Poster Viewing in Exhibit Hall
Burnham Ballroom C&D
Saturday, April 18, 2009
07:00 - 08:00
Breakfast in Exhibit Hall
Burnham Ballroom C&D
07:00 - 13:30
Exhibition Hall Open
Burnham Ballroom C&D
07:00 - 15:00
Registration Open
08:00 - 09:30
SESSION II
Clinical
Burnham Ballroom A&B
08:00 - 08:45
James Cerhan, MD
Mayo Clinic
Genetic Epidemiology: Implications for the Clinical Practitioner
08:45 - 09:30
Mathias Rummel, MD
Universitätsklinik Giessen
Koen van Besien, MD
University of Chicago
Pro-Con: Is there a role for ASCT in follicular lymphoma?
09:30 - 09:50
Break in Exhibit Hall
Burnham Ballroom C&D
09:50 - 12:20
SESSION II CONTINUED
Clinical
Burnham Ballroom A&B
09:50 - 10:35
Susan O’Brien, MD
MD Anderson Cancer Center
Treatment Options for Newly Diagnosed CLL
10:35 - 11:20
Jorge Romaguera, MD
MD Anderson Cancer Center
Treatment of mantle cell lymphoma: is upfront aggressive chemotherapy and/or transplant needed?
11:20 - 12:20
Case Discussions
Leo I. Gordon, MD
Northwestern University
Stephanie A. Gregory, MD
Rush University Medical Center
Chadi Nabhan, MD
Lurtheran General Hospital
David J. Peace, MD
University of Illinois
Scott Smith, MD, PhD
Loyola University
Patrick Stiff, MD
Loyola University
Jane N. Winter, MD
Northwestern University
12:20 - 13:15
Lunch in Exhibit Hall
Burnham Ballroom C&D
13:15 - 15:05
SESSION II CONTINUED
Clinical
Burnham Ballroom A&B
13:15 - 14:05
Michael Crump, MD
Princess Margaret Hospital
Cure, Late Effects and Prevention in Hodgkin Lymphoma
14:05 - 15:05
KEYNOTE ADDRESS
Michael
Pfreundschuh, MD
Saarland University Medical School
Perspectives on Front-line DLBCL--Current Status and the Future
